Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ASND CVE:IZN NYSE:MTT CVE:SRA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASNDAscendis Pharma A/S$198.94+0.9%$186.31$118.03▼$208.16$12.18B0.39482,811 shs197,998 shsIZNInZinc MiningC$0.03C$0.02C$0.02▼C$0.03C$3.09M1.95152886,247 shs51,000 shsMTTWestern Asset Municipal Defined Opportunity Trust$21.19$21.19$18.47▼$21.59N/AN/A26,370 shs15,402 shsSRAStria LithiumC$0.23+7.1%C$0.16C$0.05▼C$0.26C$8.87M2.05569950,043 shs54,110 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASNDAscendis Pharma A/S+1.35%-2.79%-0.54%+15.54%+41.32%IZNInZinc Mining0.00%+25.00%+25.00%-16.67%+25.00%MTTWestern Asset Municipal Defined Opportunity Trust0.00%0.00%0.00%0.00%0.00%SRAStria Lithium+7.14%+9.76%+55.17%+40.63%+200.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASNDAscendis Pharma A/S$198.94+0.9%$186.31$118.03▼$208.16$12.18B0.39482,811 shs197,998 shsIZNInZinc MiningC$0.03C$0.02C$0.02▼C$0.03C$3.09M1.95152886,247 shs51,000 shsMTTWestern Asset Municipal Defined Opportunity Trust$21.19$21.19$18.47▼$21.59N/AN/A26,370 shs15,402 shsSRAStria LithiumC$0.23+7.1%C$0.16C$0.05▼C$0.26C$8.87M2.05569950,043 shs54,110 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASNDAscendis Pharma A/S+1.35%-2.79%-0.54%+15.54%+41.32%IZNInZinc Mining0.00%+25.00%+25.00%-16.67%+25.00%MTTWestern Asset Municipal Defined Opportunity Trust0.00%0.00%0.00%0.00%0.00%SRAStria Lithium+7.14%+9.76%+55.17%+40.63%+200.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASNDAscendis Pharma A/S 3.00Buy$244.3623.14% UpsideIZNInZinc Mining 0.00N/AN/AN/AMTTWestern Asset Municipal Defined Opportunity Trust 0.00N/AN/AN/ASRAStria Lithium 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IZN, ASND, SRA, and MTT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/2/2025ASNDAscendis Pharma A/SBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$227.00 ➝ $230.008/19/2025ASNDAscendis Pharma A/SJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$254.00 ➝ $260.008/8/2025ASNDAscendis Pharma A/SCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy8/8/2025ASNDAscendis Pharma A/SWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$289.00 ➝ $295.008/8/2025ASNDAscendis Pharma A/SCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$243.00 ➝ $290.008/8/2025ASNDAscendis Pharma A/SRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$210.00 ➝ $230.008/8/2025ASNDAscendis Pharma A/SUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$306.00 ➝ $307.008/8/2025ASNDAscendis Pharma A/SWedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$212.00 ➝ $220.008/8/2025ASNDAscendis Pharma A/SCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$200.00 ➝ $203.008/8/2025ASNDAscendis Pharma A/SStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$212.00 ➝ $254.00(Data available from 9/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASNDAscendis Pharma A/S$393.54M30.86N/AN/A($1.88) per share-105.55IZNInZinc MiningN/AN/AC$0.02 per share1.20C$0.02 per shareN/AMTTWestern Asset Municipal Defined Opportunity TrustN/AN/AN/AN/AN/AN/ASRAStria LithiumN/AN/AC$0.04 per share5.19C$0.06 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASNDAscendis Pharma A/S-$409.12M-$5.16N/A826.84N/A-54.94%N/A-24.31%11/13/2025 (Estimated)IZNInZinc Mining-C$1.28M-C$0.01N/A∞N/AN/A-16.50%-9.89%N/AMTTWestern Asset Municipal Defined Opportunity TrustN/AN/A0.00∞N/AN/AN/AN/AN/ASRAStria Lithium-C$1.41MN/AN/A∞N/AN/A-62.73%-26.81%N/ALatest IZN, ASND, SRA, and MTT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025ASNDAscendis Pharma A/S-$1.42-$0.93+$0.49-$0.93$163.17 million$216.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASNDAscendis Pharma A/SN/AN/AN/AN/AN/AIZNInZinc MiningN/AN/AN/AN/AN/AMTTWestern Asset Municipal Defined Opportunity Trust$0.954.48%N/AN/AN/ASRAStria LithiumN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASNDAscendis Pharma A/SN/A1.020.69IZNInZinc MiningN/A26.5924.92MTTWestern Asset Municipal Defined Opportunity TrustN/AN/AN/ASRAStria LithiumN/A20.295.22Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASNDAscendis Pharma A/SN/AIZNInZinc Mining3.24%MTTWestern Asset Municipal Defined Opportunity TrustN/ASRAStria Lithium1.16%Insider OwnershipCompanyInsider OwnershipASNDAscendis Pharma A/S40.00%IZNInZinc Mining20.14%MTTWestern Asset Municipal Defined Opportunity TrustN/ASRAStria Lithium13.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASNDAscendis Pharma A/S1,01761.21 million36.73 millionOptionableIZNInZinc MiningN/A123.40 millionN/ANot OptionableMTTWestern Asset Municipal Defined Opportunity TrustN/AN/AN/ANot OptionableSRAStria LithiumN/A39.41 millionN/ANot OptionableIZN, ASND, SRA, and MTT HeadlinesRecent News About These CompaniesCygnus Metals Extends Pontax Lithium Project Earn-In with Share IssuanceApril 9, 2025 | tipranks.comStria Lithium Closes $650,000 Private Placement to Boost ExplorationMarch 10, 2025 | tipranks.comStria Lithium Inc. (SRA.V)January 25, 2025 | finance.yahoo.comArctic Fox Lithium Phase 2 Exploration Program Results at Pontax NorthJanuary 22, 2025 | juniorminingnetwork.comStria Lithium Ends Jeremiah Project Amid Market ShiftsDecember 4, 2024 | tipranks.comSRCAF Stria Lithium Inc.October 31, 2024 | seekingalpha.comArctic Fox Lithium completes Phase 2 exploration at Québec propertyOctober 31, 2024 | msn.comArctic Fox Lithium Completes Phase 2 Exploration Program at Pontax NorthOctober 30, 2024 | juniorminingnetwork.comStria Lithium Announces Reverse Takeover with Grafoid Inc. and Announces Changes to Executive Leadership Team and Board of Di...August 15, 2024 | br.advfn.comStria Lithium Announces Commencement of Stripping and Channel Sampling at Jeremiah ProjectMay 2, 2024 | juniorminingnetwork.comClosing Bell: Stria Lithium Inc flat on Thursday (SRA)March 9, 2024 | theglobeandmail.comStria Lithium Announces Appointment of Donald Birak to Board of DirectorsJanuary 11, 2024 | juniorminingnetwork.comStria Lithium Inc. Announces Appointment of New DirectorDecember 12, 2023 | finance.yahoo.comDiamond Drilling to Commence on High-Priority Targets at Belltopper, VictoriaNovember 14, 2023 | finance.yahoo.comIndonesia, Freeport to reach conclusion on investment, mining permit by end-Nov - govtNovember 13, 2023 | finance.yahoo.comStria Lithium Provides Update on its Newly Acquired Staked ClaimsNovember 13, 2023 | finance.yahoo.comStria Lithium Inc (SRA)November 11, 2023 | investing.comArctic Fox Completes Successful Phase 1 Exploration ProgramNovember 9, 2023 | thenewswire.comTTransUnion stock drops on disappointing outlook; shares hit six-year lowOctober 24, 2023 | proactiveinvestors.comSimply Good Foods stock higher on 4Q beat; solid guidanceOctober 24, 2023 | proactiveinvestors.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIZN, ASND, SRA, and MTT Company DescriptionsAscendis Pharma A/S NASDAQ:ASND$198.94 +1.70 (+0.86%) Closing price 03:59 PM EasternExtended Trading$199.48 +0.54 (+0.27%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.InZinc Mining CVE:IZNC$0.02 0.00 (0.00%) As of 11:33 AM EasternInZinc Mining Ltd. acquires, explores for, and develops mineral properties in the United States and Canada. It primarily explores for zinc, copper, and indium deposits. The company holds a 100% interest in the Indy project comprising an area of 19,000 hectares located in Central British Colombia; and the West Desert Property located in Utah, the United States. The company was formerly known as Lithic Resources Ltd. and changed its name to InZinc Mining Ltd. in February 2014. InZinc Mining Ltd. was incorporated in 1997 and is headquartered in Vancouver, Canada.Western Asset Municipal Defined Opportunity Trust NYSE:MTTWestern Asset Municipal Defined Opportunity Trust Inc. is a close-ended fixed income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. The fund is co-managed by Western Asset Management Company. It invests in fixed income markets of the United States. The fund makes its investments in the securities of companies operating across diversified sectors. It primarily invests its assets in a portfolio of municipal securities. The fund uses value oriented strategy to make its investments. It employs a fundamental analysis with a bottom-up stock picking approach to create its portfolio. The fund conducts in-house research to make its investments. Western Asset Municipal Defined Opportunity Trust Inc. was formed on January 15, 2009 and is domiciled in the United States.Stria Lithium CVE:SRAC$0.22 +0.02 (+7.14%) As of 09/16/2025 11:37 AM EasternStria Lithium Inc. engages in the acquisition, exploration, and development of mineral properties in Canada. It primarily explores for lithium deposits. Its flagship project is the 100% owned Pontax-Lithium that includes 68 contiguous mining claims covering an area of 3,613 hectares located in the west-central Eeyou Istchee James Bay Territory in Northern Quebec. The company was formerly known as Stria Capital Inc. and changed its name to Stria Lithium Inc. in April 2014. Stria Lithium Inc. is headquartered in Kingston, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Hits Record High After CEO Hock Tan AI Pay Package CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors Resideo Technologies: Institutional Activity Signals 30% Upside This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge Rezolute Stock: FDA Fast Track Fuels 2025 Breakout Lululemon’s Sell-Off Looks Overdone: A Contrarian Case This Defense Stock Is Up 113% This Year—Is It Still a Buy? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
